BioDelivery Sciences: Undervalued With Buyout Potential

BioDelivery Sciences International has a market capitalization of just over $300 million, enough cash on hand to fund itself through at least mid-2017 and has one approved product on the market and one more on the way.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.